ADA 2025
20 - 23 June 2025
Changes in Clinical Measures in US Adults with Type 2 Diabetes and Chronic Kidney Disease Who Received Once-Weekly Semaglutide
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.